12-Oxochenodeoxycholic Acid Analysis Service

12-Oxochenodeoxycholic acid (12-oxo-CDCA), also known as 12-Ketochenodeoxycholic acid, is the direct precursor of chenodeoxycholic acid (CDCA), which is used to dissolve cholesterol gallstones and plays a crucial role in treating cholesterol-related diseases. Primarily produced in the liver and through gut microbiota metabolism, 12-oxo-CDCA is involved in bile acid circulation and lipid metabolism. Variations in its levels are closely linked to various hepatobiliary diseases and metabolic disorders, indicating possible pathological conditions or metabolic irregularities. Precise analysis of 12-oxo-CDCA provides essential biomarkers for the diagnosis and treatment of related diseases.

Figure 1. Molecular Structure of 12-Oxochenodeoxycholic Acid

MtoZ Biolabs offers 12-Oxochenodeoxycholic Acid Analysis Service using high performance liquid chromatography-mass spectrometry (HPLC-MS). This advanced method combines the separation capabilities of HPLC with the detection power of MS, ensuring high sensitivity and specificity in 12-oxo-CDCA detection.

Analysis Workflow

Service Advantages

• Rapid Analysis Cycle and Cost-Effectiveness
• Stable, Reliable, and Highly Sensitive Results
• Comprehensive One-Stop Service for Extensive Testing Needs
• User-Friendly Operation with Wide Application Scope
• Supported by Extensive Bioanalytical Resources and Advanced Platforms

Sample Submission Requirements

For detailed sample submission instructions, please consult our technical team.

Deliverables

1. Experimental Procedures

2. Relevant Liquid Chromatography and Mass Spectrometry Parameters

3. Detailed Information on 12-Oxochenodeoxycholic Acid

4. Raw Data

5. Custom Analysis Report

MtoZ Biolabs is dedicated to advancing your research and clinical projects by providing detailed insights into 12-oxo-CDCA's extensive physiological roles through top-tier analytical techniques and expert services.